Celularity Inc (CELU)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total net revenues | 5,736 | 11,426 | 9,296 | 12,111 |
| Cost of revenue | - | - | 3,883 | 2,123 |
| Amortization of acquired intangible assets | - | 368 | 375 | 456 |
| Selling, general and administrative | 12,634 | 14,262 | 12,650 | 15,907 |
| Research and development | 3,352 | 3,728 | 3,915 | 3,800 |
| Amortization of acquired intangible assets | 372 | - | - | - |
| Cost of revenues-Service | 220 | 209 | - | - |
| Cost of revenues-Product | 2,550 | 2,506 | - | - |
| Cost of revenues-License Royalty And Other | 2,472 | 839 | - | - |
| Total operating expenses | 21,600 | 21,912 | 20,823 | 22,286 |
| Loss from operations | -15,864 | -10,486 | -11,527 | -10,175 |
| Interest income | 62 | 76 | 77 | 67 |
| Interest expense | 1,943 | 2,437 | 1,752 | 1,552 |
| Loss on debt extinguishment | - | -5,736 | - | - |
| Change in fair value of warrant liabilities | 1,276 | -242 | -714 | -7,005 |
| Other expense, net | -4,428 | -1,401 | -2,902 | -1,766 |
| Change in fair value of debt | 1,075 | 12 | 708 | 67 |
| Total other (expense) income | -8,660 | -9,268 | -4,571 | 3,687 |
| Loss before income taxes | -24,524 | -19,754 | -16,098 | -6,488 |
| Income tax expense (benefit) | - | - | - | - |
| Net loss | -24,524 | -19,754 | -16,098 | -6,488 |
| Change in fair value of debt due to change in credit risk, net of tax | -3 | 5 | - | - |
| Change in fair value of debt due to change in credit risk, net of tax | - | - | -2 | - |
| Other comprehensive (loss) income | - | - | -2 | - |
| Comprehensive loss | -24,527 | -19,749 | -16,100 | -6,488 |
| Deemed dividend relating to inducement of dragasac warrants | - | 64 | - | - |
| Net loss attributable to common shareholders | -24,527 | -19,813 | -16,100 | -6,488 |
| Net loss per share - basic | -1.02 | -0.84 | -0.73 | -0.3 |
| Net loss per share - diluted | -1.02 | -0.84 | -0.73 | -0.3 |
| Weighted average shares outstanding - basic | 24,020,193 | 23,530,877 | 21,976,339 | 21,849,759 |
| Weighted average shares outstanding - diluted | 24,020,193 | 23,530,877 | 21,976,339 | 21,849,759 |